Promoting Alternatives of Treatment for Type 2 Diabetes Study
Promoting Alternatives to Sulfonylureas to Promote Patient Safety In Type 2 Diabetes
- Sex: Any
- Age: Adult (18 - 64), Older Adult (65+)
- Accepting Healthy People: No
- Type: Interventional / Therapeutic
- Trial Phase: Phase I
- Conditions Being Studied: Diabetes Mellitus - Type 2
Study Purpose
The purpose of this study is to encourage participants with type 2 diabetes to explore alternative treatments than sulfonylureas with their primary care provider. The aim is to educate patients about alternative diabetes treatments and how to talk to their doctor about them. Some participants will be asked to participate in a qualitative interview portion of the study. A qualitative interview is an open-ended response to a question. Participants are asked open- ended question and can provide as little or as much detail in their response as they want.
Who Can Participate
Participants 45 years or older with type 2 diabetes may be eligible for this study.
Locations
UH Cleveland Medical Center
11100 Euclid Avenue
Cleveland OH, 44106
- UH IRB: N/A
- StudyID: 2024-01448
- ClinicalTrials.gov: NCT05933174
Questions or concerns? We're here to help.
Non-cancer Trials: 1-833-78TRIAL or Contact Us Online
Cancer Trials: 1-800-641-2422